NCT00616941 2022-10-12Phase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerLudwig Institute for Cancer ResearchPhase 1 Completed28 enrolled 16 charts
NCT03162562 2020-12-22The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian CancerCanariaBio Inc.Phase 1 Terminated10 enrolled
NCT02452775 2020-04-24Autologous OC-L Vaccine and Ovarian CancerAbramson Cancer Center at Penn MedicinePhase 1 Terminated3 enrolled